Get started
Author

Christoph Mikkel Janitzek

Observed names: Christoph Janitzek, Christoph M. Janitzek, Janitzek, Christoph
ORCID: 0000-0001-6529-9355
Observed ORCID: 0000-0001-6529-9355
OpenAlex ID: A5035715882
Bacterial superglue enables easy development of efficient virus-like particle based vaccines
2016 · Susan Thrane, Christoph M. Janitzek, et al. · Journal of Nanobiotechnology · 204
PDF
Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity
2021 · Cyrielle Fougeroux, Louise Goksøyr, et al. · Nature Communications · 126
PDF
Virus-like particle display of HER2 induces potent anti-cancer responses
2017 · Arianna Palladini, Susan Thrane, et al. · OncoImmunology · 124
PDF
Improving the malaria transmission-blocking activity of a Plasmodium falciparum 48/45 based vaccine antigen by SpyTag/SpyCatcher mediated virus-like display
2017 · Susheel K. Singh, Susan Thrane, et al. · Vaccine · 65
Bacterial superglue generates a full-length circumsporozoite protein virus-like particle vaccine capable of inducing high and durable antibody responses
2016 · Christoph M. Janitzek, Sungwa Matondo, et al. · Malaria Journal · 62
PDF
A Novel Virus-Like Particle Based Vaccine Platform Displaying the Placental Malaria Antigen VAR2CSA
2015 · Susan Thrane, Christoph M. Janitzek, et al. · PLoS ONE · 61
PDF
A proof-of-concept study for the design of a VLP-based combinatorial HPV and placental malaria vaccine
2019 · Christoph M. Janitzek, Julianne Peabody, et al. · Scientific Reports · 56
PDF
Therapeutic Vaccination Using Cationic Liposome-Adjuvanted HIV Type 1 Peptides Representing HLA-Supertype-Restricted Subdominant T Cell Epitopes: Safety, Immunogenicity, and Feasibility in Guinea-Bissau
2013 · Victor Raúl Gómez Román, Kristoffer Jarlov Jensen, et al. · AIDS Research and Human Retroviruses · 54
First-in-human use of a modular capsid virus-like vaccine platform: an open-label, non-randomised, phase 1 clinical trial of the SARS-CoV-2 vaccine ABNCoV2
2023 · Merel J Smit, Adam F Sander, et al. · The Lancet Microbe · 46
PDF
Virus‐like particles displaying major house dust mite allergen Der p 2 for prophylactic allergen immunotherapy
2019 · Tewarit Soongrung, Karntichar Mongkorntanyatip, et al. · Allergy · 28
A Vaccine Displaying a Trimeric Influenza-A HA Stem Protein on Capsid-Like Particles Elicits Potent and Long-Lasting Protection in Mice
2020 · Susan Thrane, Kara-Lee Aves, et al. · Vaccines · 20
PDF
Freeze-Drying of a Capsid Virus-like Particle-Based Platform Allows Stable Storage of Vaccines at Ambient Temperature
2022 · Kara-Lee Aves, Christoph M. Janitzek, et al. · Pharmaceutics · 12
PDF
The Immunogenicity of Capsid-Like Particle Vaccines in Combination with Different Adjuvants Using Different Routes of Administration
2021 · Christoph M. Janitzek, Philip H. R. Carlsen, et al. · Vaccines · 9
PDF
Two-component vaccine consisting of virus-like particles displaying hepatitis C virus envelope protein 2 oligomers
2022 · Jannick Prentoe, Christoph M. Janitzek, et al. · npj Vaccines · 8
PDF
A VAR2CSA:CSP conjugate capable of inducing dual specificity antibody responses
2017 · Sungwa Matondo, Susan Thrane, et al. · African Health Sciences · 8
PDF
Clade A HIV-1 Gag-Specific T Cell Responses Are Frequent but Do Not Correlate with Viral Loads in a Cohort of Treatment-Naïve HIV-Infected Individuals Living in Guinea-Bissau
2012 · Kristoffer Jarlov Jensen, Victor Raúl Gómez Román, et al. · Clinical and Vaccine Immunology · 4
Aotus nancymaae model predicts human immune response to the placental malaria vaccine candidate VAR2CSA
2023 · Justin Doritchamou, Morten A. Nielsen, et al. · Lab Animal · 3
PDF
Antigenic and immunogenic evaluation of permutations of soluble hepatitis C virus envelope protein E2 and E1 antigens
2021 · Jannick Prentoe, Christoph M. Janitzek, et al. · PLoS ONE · 3
PDF
Assessment of HIV-1 Patient Recruitability in the Republic of Guinea-Bissau Using African versus North American Hematology and Biochemistry Reference Intervals
2012 · Victor Raúl Gómez Román, Sanne Skov Jensen, et al. · Clinical and Vaccine Immunology · 3
Abstract 716: A novel virus-like particle vaccine presenting HER-2 extracellular domain elicits strong immune responses against mammary carcinoma
2018 · Arianna Palladini, Susan Thrane, et al. · Cancer Research
HER2 cancer vaccine optimization by combining Drosophila S2 insect cell manufacturing with a novel VLP-display technology
2018 · Thomas R. Jørgensen, Max Soegaard, et al.
MOESM2 of Bacterial superglue enables easy development of efficient virus-like particle based vaccines
2016 · Thrane, Susan, Janitzek, Christoph, et al. · Figshare
MOESM5 of Bacterial superglue enables easy development of efficient virus-like particle based vaccines
2016 · Thrane, Susan, Janitzek, Christoph, et al. · Figshare
MOESM3 of Bacterial superglue enables easy development of efficient virus-like particle based vaccines
2016 · Thrane, Susan, Janitzek, Christoph, et al. · Figshare
MOESM4 of Bacterial superglue enables easy development of efficient virus-like particle based vaccines
2016 · Thrane, Susan, Janitzek, Christoph, et al. · Figshare
Works count: 33
Citation count: 895
H-index: 12
I10-index: 12
Year
Topic
Type